Leerink Partners analyst, Geoffrey Porges, thinks that the inevitable Medivation (NASDAQ: MDVN) deal could bring another 20% to the share ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE